Eosinophilic Gastroenteritis

Clinical Trial Info

Eosinophilic Gastroenteritis

Eosinophilic gastroenteritis is a rare disease in which a type of white blood cell, the eosinophil, causes injury and inflammation to the stomach and the small intestine. Eosinophilic gastroenteritis may affect both adults and children. The cause is unknown.


  • Vomiting, nausea, diarrhea
  • Difficulty feeding and/or gaining weight
  • Poor growth and weight loss
  • Abdominal pain
  • Bloody diarrhea
  • Malnutrition
  • Fatigue

Current Clinical Trials

ClinicalTrials.gov Study Details
Eosinophilic Gastritis and/or Eosinophilic Duodenitis (Formerly Referred to as Eosinophilic Gastroenteritis) (ENIGMA 2)
Clinical Research Protocol AK002-016 A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of AK002 in Patients with Moderately to Severely Active Eosinophilic Gastritis and/or Eosinophilic Duodenitis (formerly referred to as Eosinophilic Gastroenteritis) Who Have an Inadequate Response with, Lost Response to, or Were Intolerant to Standard Therapies

Clinical Research Protocol AK002-019 A Prospective Study to Identify the Prevalence of Eosinophilic Gastrointestinal Diseases and Elevated Tissue Mast Cells among Patients with Chronic Gastrointestinal Symptoms

Dr. Lankarani reviews the link between Eosinophilic Gastroenteritis and IBS.

Contact Research
Photo of Ali Lankarani M.D.
Gastroenterologist Encore Borland Groover Clinical Research
4800 Belfort Road Jacksonville FL 32256 Contact Research: 9046800871
Return to top.